Spots Global Cancer Trial Database for A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Official Title: A Phase 2 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Study ID: NCT06425302
Conditions
Study Description
Brief Summary: The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0152, Birmingham, Alabama, United States
Local Institution - 0055, Anchorage, Alaska, United States
Local Institution - 0180, Phoenix, Arizona, United States
Local Institution - 0190, Tucson, Arizona, United States
Local Institution - 0035, San Francisco, California, United States
Local Institution - 0022, Washington, District of Columbia, United States
Local Institution - 0005, Jacksonville, Florida, United States
Local Institution - 0026, Tampa, Florida, United States
Local Institution - 0013, Peoria, Illinois, United States
Local Institution - 0019, Fairway, Kansas, United States
Local Institution - 0033, Baltimore, Maryland, United States
Local Institution - 0001, Boston, Massachusetts, United States
Local Institution - 0004, Boston, Massachusetts, United States
Local Institution - 0031, Rochester, Minnesota, United States
Local Institution - 0111, Henderson, Nevada, United States
Local Institution - 0183, Hackensack, New Jersey, United States
Local Institution - 0020, New Brunswick, New Jersey, United States
Local Institution - 0036, New York, New York, United States
Local Institution - 0052, Salt Lake City, Utah, United States
Local Institution - 0200, Norfolk, Virginia, United States
Local Institution - 0201, Norfolk, Virginia, United States
Local Institution - 0166, Seattle, Washington, United States
Local Institution - 0046, Liverpool, New South Wales, Australia
Local Institution - 0070, Brisbane, Queensland, Australia
Local Institution - 0181, Traralgon, Victoria, Australia
Local Institution - 0061, Porto Alegre, Rio Grande Do Sul, Brazil
Local Institution - 0058, Sao Paulo, São Paulo, Brazil
Local Institution - 0060, Rio de Janeiro, , Brazil
Local Institution - 0056, São Paulo, , Brazil
Local Institution - 0064, Toronto, Ontario, Canada
Local Institution - 0049, Santiago, Región Metropolitana De Santiago, Chile
Local Institution - 0050, Santiago, Región Metropolitana De Santiago, Chile
Local Institution - 0101, Saint-Cloud, Hauts-de-Seine, France
Local Institution - 0103, Lille, Nord, France
Local Institution - 0121, Poitiers, Vienne, France
Local Institution - 0118, Paris, , France
Local Institution - 0197, Regensburg, Bayern, Germany
Local Institution - 0188, Chemnitz, Sachsen, Germany
Local Institution - 0189, Dresden, , Germany
Local Institution - 0198, Rome, Lazio, Italy
Local Institution - 0179, Rozzano, Milano, Italy
Local Institution - 0096, Bari, Puglia, Italy
Local Institution - 0098, Bari, Puglia, Italy
Local Institution - 0097, Bari, , Italy
Local Institution - 0076, Bologna, , Italy
Local Institution - 0075, Napoli, , Italy
Local Institution - 0104, Hwasun Gun, Jeonranamdo, Korea, Republic of
Local Institution - 0100, Busan, Pusan-Kwangyǒkshi, Korea, Republic of
Local Institution - 0085, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of
Local Institution - 0086, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of
Local Institution - 0186, Bydgoszcz, Kujawsko-pomorskie, Poland
Local Institution - 0185, Warszawa, Mazowieckie, Poland
Local Institution - 0187, Skorzewo, Wielkopolskie, Poland
Local Institution - 0196, Palma, Balears [Baleares], Spain
Local Institution - 0192, Valencia, Valenciana, Comunitat, Spain
Local Institution - 0191, Madrid, , Spain
Local Institution - 0094, Kaohsiung, , Taiwan
Local Institution - 0092, Kaohsiung, , Taiwan
Local Institution - 0123, Taipei, , Taiwan
Local Institution - 0175, Southampton, Hampshire, United Kingdom
Local Institution - 0112, Canterbury, Kent, United Kingdom
Local Institution - 0115, Edinburgh, Midlothian, United Kingdom
Local Institution - 0105, Nottingham, , United Kingdom
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
